841 adult participants ( aged 18 years ) with inadequately controlled type 2 diabetes and a BMI between 20 and 45 kg/m ( 2 ) were enrolled and randomised in a 1:1 ratio to receive albiglutide 30 mg once weekly titrated to 50 mg at week 6 , or liraglutide 06 mg once daily titrated to 12 mg at week 1 and 18 mg at week 2 .